Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sight Sciences, Inc.SGHT · Entity 5537 | Director | June 08, 2023 | June 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sight Sciences, Inc.
Report date June 08, 2023 · Filed June 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,940 |
Reported balance
After 2023-06-08 transaction · row 1
1 source rowRow 1 · 2023-06-08 · Grant · Acquired 11,940 · Balance 11,940 F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program, as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs vested in full on June 8, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program, as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs vested in full on June 8, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2023 Filed Jun 12, 2023 21:59 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-015399 · doc4.xml · nonDerivative · entry 1 Schroeder Valeska · CIK 0001870428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,940 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program, as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs vested in full on June 8, 2023. Read SEC document |
| June 08, 2022 Filed Aug 5, 2022 20:12 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantRestricted Stock Units · Derivative | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-027825 · doc4.xml · derivative · entry 1 Schroeder Valeska · CIK 0001870428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.